Attenuated dengue 2 viruses with deletions in capsid protein derived from an infectious full-length cDNA clone
- 6 April 2007
- journal article
- Published by Elsevier in Virus Research
- Vol. 126 (1-2) , 226-232
- https://doi.org/10.1016/j.virusres.2007.03.004
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- RNA Secondary Structure in the Coding Region of Dengue Virus Type 2 Directs Translation Start Codon Selection and Is Required for Viral ReplicationJournal of Virology, 2006
- rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult VolunteersThe Journal of Infectious Diseases, 2005
- Mimicking live flavivirus immunization with a noninfectious RNA vaccineProceedings of the National Academy of Sciences, 2004
- Inefficient Signalase Cleavage Promotes Efficient Nucleocapsid Incorporation into Budding Flavivirus MembranesJournal of Virology, 2004
- Flavivirus Capsid Is a Dimeric Alpha-Helical ProteinJournal of Virology, 2003
- Requirements for Signal Peptide Peptidase-Catalyzed Intramembrane ProteolysisMolecular Cell, 2002
- Capsid Protein C of Tick-Borne Encephalitis Virus Tolerates Large Internal Deletions and Is a Favorable Target for Attenuation of VirulenceJournal of Virology, 2002
- Structure of Dengue VirusCell, 2002
- Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.The American Journal of Tropical Medicine and Hygiene, 2001
- Report of a fatal case of dengue infection with hepatitis: Demonstration of dengue antigens in hepatocytes and liver apoptosisHuman Pathology, 1999